A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R. +42 more·2020·Nature Medicine
DOI 10.1038/s41591-020-1038-6

Cited by (953)

Items 701–800 of 953

  1. Hemostatic Profile and Serum Levels of Interferon Gamma-Induced Protein 10 (IP-10) in Neonates Born to Mothers with COVID-19 During the Peripartum Period
    Rozeta Sokou, Efstathia-Danai Bikouli, Andreas G. Tsantes, Panagiotis Halvatsiotis, Dimitra Panagiotis Houhoula, Paschalia Kopanou Taliaka, Paraskevi Liakou, Evangelia‐Filothei Tavoulari, Daniele Piovani, Stefanos Bonovas et al. · 2025 · International Journal of Molecular Sciences
  2. Identification of biomarkers in Alzheimer’s disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms
    Juntu Li, Linfeng Tao, Yanyou Zhou, Yue Zhu, Chao Li, Yiyuan Pan, Ping Yao, Xuefeng Qian, Jun Liu · 2025 · PLoS ONE
  3. Insights into the virologic and immunologic features of SARS-COV-2
    Ceylan Polat, Koray Ergünay · 2021 · World Journal of Clinical Cases
  4. Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
    Nishkantha Arulkumaran, Timothy Arthur Chandos Snow, Adarsh Kulkarni, David A. Brealey, Hannah M. Rickman, Chloe Rees-Spear, Moira J. Spyer, Judith Heaney, Edmund Garr, Bryan Williams et al. · 2021 · Critical Care Explorations
  5. A case report describing the immune response of an infant with congenital heart disease and severe COVID-19
    Danielle F. Wurzel, Melanie R. Neeland, Jeremy Anderson, Yara‐Natalie Abo, Lien Anh Ha Do, Celeste M. Donato, Julie E. Bines, Zheng Quan Toh, Rachel A. Higgins, Sedi Jalali et al. · 2021 · Communications Medicine
  6. An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results
    Marzena Zalewska−Ziob, Wiktoria Fus, Adam Konka, Karolina Wystyrk, Aneta Bochenek, Hanna Botor, Martyna Fronczek, Joanna Zembala-John, Brygida Adamek · 2022 · Vaccines
  7. Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites
    Yekbun Adıgüzel, Yehuda Shoenfeld · 2022 · Antibodies
  8. Characteristic Immune Dynamics in COVID-19 Patients with Cardiac Dysfunction
    Filipe André Gonzalez, Miguel Ângelo‐Dias, Catarina Gregório Martins, Rui M. Gomes, Jacobo Bacariza Blanco, Antero Fernandes, Luís Miguel Borrego, EchoCrit Group · 2022 · Journal of Clinical Medicine
  9. Longitudinal analyses reveal age-specific immune correlates of COVID-19 severity
    Sloan A. Lewis, Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Amanda N. Pinski, Micaila Curtis, Allen Jankeel, Izabela Coimbra Ibraim, Nicholas S. Rhoades, Xiwen Jiang et al. · 2021 · medRxiv
  10. Circulating proteins to predict adverse COVID-19 outcomes
    Chen‐Yang Su, Sirui Zhou, Edgar Gonzalez‐Kozlova, Guillaume Butler‐Laporte, Elsa Brunet‐Ratnasingham, Tomoko Nakanishi, Wonseok Jeon, David Morrison, Laetitia Laurent, Jonathan Afilalo et al. · 2021 · medRxiv
  11. AImmune: a new blood-based machine learning approach to improving immune profiling analysis on COVID-19 patients
    Runpeng Harris Han, Xi Tom Zhang · 2021 · medRxiv
  12. Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control
    Tao Dong, Guihai Liu, Suet Ling Felce, Xuan Yao, Zixi Yin, Anastasia Fries, Alexander J. Mentzer, Danning Dong, Wenbo Wang, Wanwisa Dejnirattisai et al. · 2022 · Research Square
  13. Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence
    Jack Gisby, Norzawani B Buang, Artemis Papadaki, Candice Clarke, Talat H. Malik, Nicholas Medjeral‐Thomas, Damiola Pinheiro, Paige M Mortimer, Shanice Lewis, Eleanor Sandhu et al. · 2022 · medRxiv
  14. Infection-induced vascular inflammation in COVID-19 links focal microglial dysfunction with neuropathologies through IL-1/IL-6-related systemic inflammatory states
    Rebeka Fekete, Alba Simats, Eduárd Bíró, Csaba Cserép, Anett D. Schwarcz, Balázs Pósfai, Eszter Szabadits, Zsuzsanna Környei, Krisztina Tóth, Anna Kellermayer et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Kidney Issues Associated with COVID-19 Disease
    Periklis Dousdampanis, Αthanasia Mouzaki, Konstantina Trigka, Ioannis Stefanidis, Konstantinos-Eugenios Galanopoulos, Ioannis-Santo Siavelis, Dionysia Stathopoulou, Stelios F. Assimakopoulos · 2023 · Encyclopedia
  16. Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
    Marta Di Simone, Anna Maria Corsale, Elena Lo Presti, Nicola Scichilone, Carmela Picone, Lydia Giannitrapani, Francesco Dieli, Serena Meraviglia · 2022 · Cells
  17. Early inflammatory profiles predict maximal disease severity in COVID-19: An unsupervised cluster analysis
    Grace Kenny, Gurvin Saini, Colette Marie Gaillard, Riya Negi, Dana Alalwan, Alejandro Garcia Leon, Kathleen McCann, Willard Tinago, Christine Kelly, Aoife G. Cotter et al. · 2024 · Heliyon
  18. Bayesian Modeling of the Impact of HBOT on the Reduction in Cytokine Storms
    Natalia Jermakow, Klaudia K. Brodaczewska, Jacek Kot, Arkadiusz Lubas, Krzysztof Kłos, Jacek Siewiera · 2025 · Journal of Clinical Medicine
  19. Endothelial Activation and Stress Index (EASIX) to Predict the Outcome of Patients with COVID-19
    Derya Gökçınar, Ayşe Lafçı, Şeval İzdeş · 2025 · COVID
  20. COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions
    Zahra Farjami, Mina Moradi, Neshat Ebrahimi, Mohammad Mehdi Akbarin · 2025 · Viral Immunology
  21. The double threat: bacterial and fungal co-/superinfection in viral pneumonia
    Arsah Asis, Alejandro Rodriguez, Luis Felipe Reyes, Emili Dı́az, Saad Nseir, Ignacio Martín‐Loeches · 2026 · Expert Review of Respiratory Medicine
  22. Viral evolution during primary infection in immunocompromised hosts
    Morgan Craig, Xiaoyan Deng, David V. McLeod · 2026 · PLoS Computational Biology
  23. Management of Severe and Critical COVID-19 Infection with Immunotherapies
    Janhavi Athale, Jolie Gallagher, Lindsay M. Busch · 2022 · Infectious Disease Clinics of North America
  24. Sustained Cytotoxic Response of Peripheral Blood Mononuclear Cells from Unvaccinated Individuals Admitted to the ICU Due to Critical COVID-19 Is Essential to Avoid a Fatal Outcome
    Guiomar Casado‐Fernández, Magdalena Corona, Montserrat Torres, Adolfo Sáez, Fernando Ramos-Martín, Mario Manzanares, Lorena Vigón, Elena Mateos, Francisco Pozo, Inmaculada Casas et al. · 2023 · International Journal of Environmental Research and Public Health
  25. Markers of inflammasome activation in Coronavirus disease 2019 (COVID-19) Egyptian patients: Impact on disease severity
    S Abd El-Rahim Abd El-Aty, Shaaban Ahmed, Rawhia F. Abd El-Hamid, Asmaa Mohamed Zahran, Doaa Mohamed Magdy, Omnia Bakr Badawy, Nahla M. Elsherbiny · 2023 · Egyptian journal of Immunology
  26. Obesity in Severe COVID-19 Patients Has a Distinct Innate Immune Phenotype
    Ayane de Sá Resende, Yrna Lorena de Oliveira, Mariana Nobre Farias de Franca, Lucas Sousa Magalhães, Cristiane Bani Corrêa, Kiyoshi F. Fukutani, Michael W. Lipscomb, Tatiana Rodrigues de Moura · 2023 · Biomedicines
  27. Amino Acid Metabolism in Leukocytes Showing In Vitro IgG Memory from SARS-CoV2-Infected Patients
    Giuseppina Fanelli, Veronica Lelli, Sara Rinalducci, Anna Maria Timperio · 2024 · Diseases
  28. The Dysregulation of the Monocyte–Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia
    Domenico Galati, Domenico Mallardo, Carmine Nicastro, Serena Zanotta, Ludovica Capitelli, Carmen Lombardi, Bianca Baino, Ernesta Cavalcanti, Silvia Sale, Francesco Labonia et al. · 2024 · Journal of Clinical Medicine
  29. IP-10, MIP1α, IL-6, and IL-1β as Biomarkers Associated with Disease Severity of COVID-19
    Sanaz Paikar, Naghmeh Bahrami, R Rafiee Tabatabai, Abdolreza Mohamadnia · 2024 · Jundishapur Journal of Microbiology
  30. Decrease of Tregs cells and increase of exhausted Treg cells as the predictors of COVID19 severity
    Seyed Mehdi Mirniam, Alireza Andalib, Maedeh Radandish, Ramin Sami, Nafiseh Esmaeil · 2024 · Journal of Clinical Virology Plus
  31. Predictive value of inflammatory factors and lymphocyte counts in tracheal intubation and death after infection with COVID-19
    Zhongying Xu, Guomin Jin, Debao Zhang · 2024 · BMC Pulmonary Medicine
  32. Analysis of the dynamics of gene expression in patients with acute COVID-19 and in recovery period
    Irina Kadyrova, Valentina Barkhanskaya · 2024 · Medicine and ecology
  33. Key actors in neuropathophysiology: The role of γδ T cells
    Deniz Bulgur, Raquel Macedo Moura, Julie C. Ribot · 2024 · European Journal of Immunology
  34. A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories
    João Luiz Silva‐Filho, Vanessa Herder, Matthew P. Gibbins, Monique Freire Santana, Gisely Cardoso de Melo, Michael Haley, Carla C. Judice, Fernando Val, Mayla Gabriela Silva Borba, Tatyana Almeida Tavella et al. · 2024 · Science Translational Medicine
  35. Circulating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: A prospective multicenter study of the European DRAGON consortium
    Barbara Polese, Marie Ernst, Monique A. Henket, Benoit Ernst, Marie Winandy, Makon‐Sébastien Njock, Céline Blockx, Stéphanie Kovacs, Florence Watar, Anna Julie Peired et al. · 2024 · Journal of Infection and Public Health
  36. Systemic inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody
    Christopher W. Farnsworth, B. Roemmich, J. Prostko, G. Davis, G. Murtagh, L. Jackson, C. Jacobson, N. Jeanblanc, T. Griffiths, E. Frias et al. · 2025 · Microbiology spectrum
  37. Role of monocytes in immunopathogenesis of infectious and inflammatory diseases: from theory to practice
    Andrey S. Trulioff, Alexandr G. Borisov, Игорь Владимирович Кудрявцев, Vladimir A. Lazanovich, Andrei A. Savchenko · 2024 · Medical academic journal
  38. Using ‘big data’ to disentangle aging and COVID-19
    Ruth R. Montgomery, Hanno Steen · 2021 · Nature Aging
  39. Participación de las respuestas inmunes en el control de la COVID-19
    Cristina Pérez · 2022 · Revista Ecuatoriana de Medicina y Ciencias Biológicas
  40. NK cells at the crossroads in COVID-19: a question of timing
    Susana del Toro‐Arreola, Fabiola Solorzano Ibarra, Martha Cecilia Téllez‐Bañuelos, Jesse Haramati · 2020 · Ciencia Tecnologí­a y Salud
  41. Personal observations on COVID-19 and the conduct and application of biomedical science
    James C. Smith, David W. Goodhew · 2021 · Interface Focus
  42. Clinical surrogates of dysautonomia predict lethal outcome in COVID-19 on intensive care unit
    Marcel S. Woo, Christina Mayer, Marlene Fischer, Stefan Kluge, Kevin Roedl, Christian P Gerloff, Patrick Czorlich, Götz Thomalla, Julian Schulze zur Wiesch, Nils Schweingruber · 2023 · Neurological Research and Practice
  43. Prédicteurs biologiques de mortalité chez les patients atteints de la Covid-19 : Etude observationnelle de suivi historique monocentrique à Kinshasa
    Jonathan Ibana Kukila, Blaise Matondo-Manzambi Sumbu, Merlin Yoka Matena, Yves Muzinga Mukaba, Clelie Clelie Mbwinzo, Donat Kalombo Muamba, Jeremie Masidi Muwonga · 2024 · Annales Africaines de Medecine
  44. A Review on Role of Inflammation in Coronavirus Disease
    Arezoo Lotfi, Pouran Hajian, Laleh Abbasi, Morad Kohandel Gargari, Najmeh Nameh Goshay Fard, Delaram Naderi · 2024 · Endocrine Metabolic & Immune Disorders - Drug Targets
  45. Correlation between Serum Biomarkers and Lung Ultrasound in COVID-19: An Observational Study
    Amne Mousa, Siebe G. Blok, Dian Karssen, Jurjan Aman, Jouke Tabe Annema, Harm Jan Bogaard, Peter Iwan Bonta, Mark Evert Haaksma, Micah L. A. Heldeweg, Arthur W. E. Lieveld et al. · 2024 · Diagnostics
  46. The Diagnostic and Predictive Value of Biomarkers for Pulmonary Fibrosis in Patients with Coronavirus Disease 2019
    Jiapei Lv, Chen Liping, Huaying Wang · 2024 · Journal of Global Infectious Diseases
  47. Uncovering the Contrasts and Connections in PASC: Viral Load and Cytokine Signatures in Acute COVID-19 versus Post-Acute Sequelae of SARS-CoV-2 (PASC)
    Brandon Compeer, Tobias R. Neijzen, Steven F. L. van Lelyveld, B. E. E. Martina, Colin A. Russell, Marco Goeijenbier · 2024 · Biomedicines
  48. HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY
    Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando · 2020 · Mediterranean Journal of Hematology and Infectious Diseases
  49. Procalcitonin as a Prognostic Factor in Patients with COVID-19 in Southwestern Iran
    Milad Shahini Shams Abadi, Elham Taheri, Ahmad Raesi, Mohammad‐Hassan Arjmand, Soleiman Kheirii, Najmeh Shahinfard, Zahra Habibi · 2022 · Infectious Disorders - Drug Targets
  50. Anti-type I interferon antibodies as a cause of severe COVID-19
    David C. Fajgenbaum, Adrian Hayday, Angela J. Rogers, Greg J. Towers, Andreas Wack, Ivan Zanoni · 2022 · Faculty Reviews
  51. Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19
    Norikazu Mataki, Hiroki Ohmura, Tatsuya Kodama, Satoko Nakamura, Yoshiko Kichikawa, Kouichi Nishimura, Michio Nakai, Mayu Nagura‐Ikeda, Sakiko Tabata, Kazuyasu Miyoshi et al. · 2020 · Journal of Infection
  52. Precast concrete wall-foundation connection. Development of a seismic dissipative connection
    Rui Marreiros · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  53. Plasmacytoid dendritic cells regulate megakaryocyte and platelet homeostasis
    F. Gaertner, H. Ishikawa-Ankerhold, Susanne Stutte, Wen-Wen Fu, Chenglong Guo, J. Weitz, A. Dueck, Zhe Zhang, Dominic van den Heuvel, Valeria Fumagalli et al. · 2022 · bioRxiv
  54. CD98 is critical for a conserved inflammatory response to diverse injury stimuli relevant to IPF exacerbations and COVID pneumonitis
    Panayiota Stylianou, Sara Rushwan, Wei Wang, M. Azim Miah, Omeed Darweesh, Alison C. MacKinnon, Katy Morgan Roach, Charlie J. Hitchman, Oksana Gonchar, Stephen D. Thorpe et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Neutrophil proteomics identifies temporal changes and hallmarks of delayed recovery in COVID19
    Merete Bridget Long, Andrew J.M. Howden, Holly Rachael Keir, Christina M. Rollings, Yan Hui Giam, Thomas Pembridge, Lilia Delgado, Hani Abo-Leyah, Amy F. Lloyd, Gabriel Sollberger et al. · 2022 · medRxiv
  56. Tocilizumab treatment leads to early resolution of lymphopenia and myeloid dysregulation in patients hospitalized with COVID-19
    Haridha Shivram, Jason A. Hackney, Carrie M. Rosenberger, Anastasia A. Teterina, Aditi Qamra, Olusegun O. Onabajo, Jacqueline McBride, Fang Cai, Min Bao, Larry W. Tsai et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Characterization of CXCL10 as a biomarker of respiratory tract infections detectable by open-source lateral flow immunoassay
    Dayna Mikkelsen, Jennifer A. Aguiar, Benjamin J.-M. Tremblay, Manjot S. Hunjan, Ulrich Eckhard, Jodi Gilchrist, David C. Bulir, Marek Smieja, Samira Mubareka, Catherine Lambert et al. · 2024 · medRxiv
  58. Levilimab clinical efficacy for interleukin-6 receptor inhibition in COVID-19 and its potential for treating cytokine release syndrome of other aetiologies
    Nikita V. Lomakin, Б. А. Бакиров, G. Musaev, Vladimir V. Popov, Е. А. Smolyarchuk, Yu. N. Linkova, D. V. Bogdan, Еремеева Анна Викторовна, П. С. Пухтинская, Maria A. Morozova et al. · 2022 · Biological Products Prevention Diagnosis Treatment
  59. T cell responses to SARS-COV-2
    Laiqha Khadri, Mohammad Hossein Ziraksaz, Ahmad Bashir Barekzai, Baber Ghauri · 2023 · Progress in molecular biology and translational science
  60. Heterogeneity and longitudinal transcriptomic characteristics of Tregs in COVID-19 patients
    Yanling Wen, Juanjuan Zhao, Zheng Zhang · 2025 · Frontiers in Immunology
  61. In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar.
    N. Vaikath, M. Al-Nesf, N. Majbour, Houari B. Abdesselem, Vijay Gupta, Ilham Bensmail, Ilham Y. Abdi, K. A. Elmagarmid, Shadah Shabani, Indulekha P Sudhakaran et al. · 2025 · Journal of Infection and Public Health
  62. Macrophage Migration Inhibitory Factor and Post-Discharge Inflammatory Profiles in Severe COVID-19: A Prospective Observational Study from Romania
    Nimród László, Corina Mărginean, B Matyas, Cristina Alexandra Man, Előd Ernő Nagy, Gabriela Jimborean · 2025 · International Journal of Molecular Sciences
  63. From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk
    Rufaida Wasim · 2025 · Inflammopharmacology
  64. COVID-19 Is Airborne AIDS: Provocative Oversimplification, Emerging Science, or Something in Between?
    Špela Šalamon, Arneaux Kruger, Deborah A. Lupton, Etheresia Pretorius, Andrew G. Ewing, Yaneer Bar‐Yam · 2025 · AJPM Focus
  65. Impact of Gestational Maternal SARS‐CoV‐2 Infection on Neonatal Inflammatory Biomarkers
    Bushra Amreen, Floriana Milazzo, Frederieke A. J. Gigase, Darwin D’souza, Natalie Samper, Joseph Thomas Martin, Seunghee Kim‐Schulze, Whitney Lieb, Lot D. de Witte, Veerle Bergink et al. · 2026 · American Journal of Reproductive Immunology
  66. Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
    Olivia Lenoir, Florence Morin, Anouk Walter‐Petrich, Léa Resmini, Mohamad Zaidan, Nassim Mahtal, Sophie Ferlicot, Victor G. Puelles, Nicola Wanner, Julien Dang et al. · 2026 · JCI Insight
  67. Immune dysregulation in COVID-19: Mathematical modeling of the within-host dynamics
    Keopagnapech Ngoun, Nicolas Alvarez, Ayesh Awad, Hwayeon Ryu · 2026 · Mathematical Biosciences & Engineering
  68. BCG Vaccination Modulates Long-Term TNF-α and sCD40L in COVID-19: An Exploratory Longitudinal Study
    Caroline Fávero, Gabriela Barbosa, Vanessa Pellegrini, Dayane Melo, Shahrokh François Shariat, Lívia Pascoal, Leonardo Reis · 2026 · International Journal of General Medicine
  69. Temporal analyses of immune responses in sepsis reveal asynchrony between clinical stage of illness and immune states
    Matthew Fish, Jennifer Rynne, Emma M. Timms, Aislinn Jennings, Carolynn Lam, Gill Arbane, Neus Grau Novellas, Sara Campos, Barney Sanderson, Paolo Bosco et al. · 2026 · Immunity
  70. Caspase-11–mediated hyperinflammation impairs CD8+ T cell immunity and viral clearance in severe SARS-CoV-2 infection
    Mostafa M. Eltobgy, Mohamed M. Shamseldin, Owen D. Whitham, Heba M. Amer, Jeffrey Atkinson, Asmaa Badr, Jesse M. Hall, Gauruv A. Gupta, Yara Y. Hassan, Rabab ElMergawy et al. · 2026 · JCI Insight
  71. Virological Correlates of IgM–IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens
    Pablo Barreiro, Francisco Javier Candel, Juan Carlos Sanz, Jesús San Román, María del Mar Carretero, Marta Pérez-Abeledo, Belén Ramos, José Manuel Viñuela-Prieto, Jesús Canora, Francisco Javier Martínez-Peromingo et al. · 2021 · Viruses
  72. EMPLOYMENT BASED ON A FICTION: EVALUATING THE LEGITIMACY OF TRADITIONAL NOTIONS OF CONTRACT IN THEIR APPLICATION TO AN ATYPICAL EMPLOYMENT RELATIONSHIP
    Andre M Louw · 2022 · Obiter
  73. Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019
    Pablo Guisado‐Vasco, José Aguareles, María Mateos González, Gabriel Sotres-Fernández, Daniel Carnevali Ruiz · 2022 · The Journal of Infectious Diseases
  74. Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: A comparative analysis across two New York hospitals
    Ben C. Lambert, Isaac J. Stopard, Amir Momeni Boroujeni, Rachelle Mendoza, Alejandro R. Zuretti · 2022 · PLoS ONE
  75. Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19
    Julij Šelb, Barbara Bitežnik, Urška Bidovec‐Stojkovič, Boštjan Rituper, Katarina Osolnik, Peter Kopač, Petra Svetina, Kristina Cerk Porenta, Franc Šifrer, Petra Lorber et al. · 2022 · ERJ Open Research
  76. Clinical and computed tomography features of patients suspected of COVID-19 in the university hospital of Oran, Algeria.
    Abdelmadjid Snouber, Malika Métahri, Salaheddine Chahraoui, Dalila Benatta, Sihem Boukhari, Amine Hadjouj, Djamila Larbi, Mahmoud Rahmani, Mostefa Douichine, Amina Zouaoui et al. · 2022 · PubMed Central
  77. Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
    Zuzana Nová, Tomáš Zemánek, N Botek · 2022 · International Journal of Molecular Sciences
  78. Cytokine Profiling in COVID-19 Patients in a Tertiary Hospital in Saudi Arabia; the Pre-Storm Phase
    Mayyadah H. Alabdely, Walter Conca, Morad Ahmed Alkaff, Aziza Alonaizie, Futwan A Al-Mohanna, Futwan A Al-Mohanna, Walter Conca, Walter Conca, Walter Conca · 2022 · International Journal of Coronaviruses
  79. In silico study of molecular mimicry between SARS-CoV-2 and neutrophil extracellular traps composition in granulocyte-rich supernatants of patients with systemic lupus erythematosus and lupus nephritis
    Yekbun Adıgüzel, Yehuda Shoenfeld · 2023 · Elsevier eBooks
  80. Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population
    Allison B Chambliss, Mayada A. Aljehani, Brian H. Tran, Xingyao Chen, Elizabeth Elton, Carolina Garri, Nolan M. Ung, Naim Matasci, Mitchell Eric Gross · 2023 · Practical Laboratory Medicine
  81. Hemodialysis: The Life Boat for AKI Patients in the COVID Cytokine Storm
    Eesha Shukla, Upma Narain, Arvind Gupta · 2023 · Indian Journal of Nephrology
  82. Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia
    Allison C. Billi, Rachael Wasikowski, Feiyang Ma, Srilakshmi Yalavarthi, Claire K. Hoy, Yu Zuo, Matthew T. Patrick, Neha Shah, Christine Parker, Chad Aaronson et al. · 2023 · JCI Insight
  83. Myocarditis and COVID-19 related issues
    Michele Ciabatti, Chiara Zocchi, Iacopo Olivotto, Leonardo Bolognese, Maurizio Pieroni · 2023 · Global Cardiology Science and Practice
  84. Molecular Mimicry Study Between Peptides of SARS-CoV-2 and Neutrophil Extracellular Traps-Related Proteins
    Yekbun Adıgüzel, Yehuda Shoenfeld · 2024 · Elsevier eBooks
  85. Cytokine regulation disbalance: the basis for COVID-19 immunopathogenesis
    Andrey S. Simbirtsev · 2023 · Cytokines and inflammation
  86. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases
    Francis Edem Agamah, Thomas H. A. Ederveen, Michelle Skelton, Darren Patrick Martin, Emile Rugamika Chimusa, Peter A.C. ’t Hoen · 2024 · Drug repurposing
  87. An explainable machine learning model for COVID-19 severity prognosis at hospital admission
    Antonios T. Tsanakas, Yvonne M. Mueller, Harmen J.G. van de Werken, Ricardo Pujol‐Borrell, Christos A. Ouzounis, Peter D. Katsikis · 2024 · Informatics in Medicine Unlocked
  88. Evaluation of Pentraxin-3 levels in children with multisystem inflammatory syndrome
    Dolunay Gürses, Münevver Yılmaz, Esin Avcı, Merve Oğuz, Emine Sayın, Selçuk Yüksel · 2024 · Cardiology in the Young
  89. Dampak COVID-19 Pada Saham Perusahaan Farmasi di Bursa Efek Indonesia: Analisis Pasar Modal Indonesia
    Fransisca Tharia Hartanto, John Iwan Kusno · 2024 · Akuntansi dan Manajemen
  90. Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients
    Rita Casetti, Alessandra Sacchi, Valentina Mazzotta, Flavia Cristofanelli, Germana Grassi, Simona Gili, Eleonora Cimini, Stefania Notari, Veronica Bordoni, Ilaria Mastrorosa et al. · 2025 · International Immunopharmacology
  91. Methylation patterns of the nasal epigenome of hospitalized SARS-CoV-2 positive patients reveal insights into molecular mechanisms of COVID-19
    Benjamin L. Spector, Boryana S. Koseva, Rebecca McLennan, Dithi Banerjee, Kamani M. Lankachandra, Todd Bradley, Rangaraj Selvarangan, Elin Grundberg · 2025 · BMC Medical Genomics
  92. Phagocytic activity of blood monocytes and neutrophils in moderate COVID-19 patients and impact of immune therapy with bacterial lysates
    М. П. Костинов, О. А. Свитич, А. Г. Чучалин, Viliya Gajnitdinova, Irina V. Bisheva, Svetlana Anatolyevna Skhodova, V. N. Osiptsov, V. R. Tatevosov, Nadezhda Kryukova, Isabella Khrapunova et al. · 2025 · PLoS ONE
  93. Downs syndrom og covid-19 – en oversett risikogruppe?
    Maria Belland Olsen · 2020 · Tidsskrift for Den norske legeforening
  94. Immunsystemets rolle i alvorlig covid-19
    Maria Belland Olsen, Ida Gregersen · 2020 · Tidsskrift for Den norske legeforening
  95. MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED SARS-COV-2. A NOVEL SPECTRUM OF PEDIATRIC ILNESS
    Simona Sorana Cainap, Alexandra Mititelu, Oana Pantar, Diana Lazar · 2021 · The Journal of School and University Medicine
  96. Management protocol of hospitalized patients with COVID-19 in Babcock University Teaching Hospital, Ilishan-Remo, Ogun State, Nigeria
    John Omotola Ogunkoya, Akolade Idowu, Charles John Elikwu, Titus Ayodeji Oyedele, Akindele Emmanuel Ladele, KE Tuta, Emmanuel Fikayo Bamidele · 2021 · Babcock University Medical Journal
  97. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm?
    Hüseyin Sütlüoğlu, Öner Özdemır · 2021 · World Journal of Transplantation
  98. Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patients
    Bilal Akhter Mateen, Sandip Samanta, Sebastian Tullie, Sarah O’Neill, Zillah Cargill, Gillian Kelly, Ewen Brennan, Mehul Patel, Mohammad Al-Agil, James Benjamin Galloway et al. · 2021 · BMJ Open Gastroenterology
  99. A call for discovery: Re‐envisioning The Cancer Genome Atlas as a blueprint for a TCGA2.0—The COVID‐19 Genome Atlas
    Kristian Michael Hargadon · 2021 · Clinical and Translational Discovery
  100. The immunomodulatory effects of Qushi Jianpi Hewei Decoction (QJHD) for patients with COVID-19 by metagenomics and transcriptomic sequencing
    Jinhui Li, Yichang Yang, Bing Xiong, Jing Lü, You Zhou, Caixia Li, Xiao Hu · 2022 · Pharmacological Research - Modern Chinese Medicine